Skip to main content

Advertisement

Table 2 Virologic response results

From: Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

Follow up time(weeks) Number of studies Test of hetergeneity Analysis model Results RR (95% CI) P-value
   I2 P   LAM + ADV (n/N) ETV (n/N)   
12 4 0% 0.72 Fixed effect model 75/140 70/147 1.08[0.87,1.34] 0.51
24 4 0% 0.83 Fixed effect model 101/140 94/145 1.09[0.93,1.26] 0.29
48 4 0% 0.63 Fixed effect model 126/140 116/147 1.14[1.03,1.26] 0.01
96 3 82% 0.003 Randomed effect model 102/106 87/105 1.13[0.93,1.38] 0.23